JNJ-1900 enhances radiation therapy effects while minimizing damage to healthy lung tissue, offering a promising approach for lung cancer treatment. Intratumoral therapies can reduce early treatment ...
ST. LOUIS--(BUSINESS WIRE)--Kinimmune, a clinical-stage biopharmaceutical company focused on the discovery and development of localized immunotherapies, announced the publication of clinical results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback